{"nctId":"NCT04263454","briefTitle":"The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia","startDateStruct":{"date":"2020-03-11","type":"ACTUAL"},"conditions":["Fibromyalgia"],"count":36,"armGroups":[{"label":"Healthy Control","type":"OTHER","interventionNames":["Drug: Endotoxin, Escherichia Coli","Procedure: Magnetic Resonance Spectroscopy"]},{"label":"Fibromyalgia","type":"EXPERIMENTAL","interventionNames":["Drug: Endotoxin, Escherichia Coli","Procedure: Magnetic Resonance Spectroscopy"]}],"interventions":[{"name":"Endotoxin, Escherichia Coli","otherNames":["Endotoxin"]},{"name":"Magnetic Resonance Spectroscopy","otherNames":["MRI"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Female;\n* Age 18-55, inclusive;\n* Adequate English for study participation;\n* (fibromyalgia group only) Meet 2010 American College of Rheumatology criteria for the diagnosis of fibromyalgia\n* Able to undergo IV cannulation and to provide the requisite blood samples;\n* BMI 18-39.9 inclusive;\n* Resting heart rate ≥55\n* Supine systolic blood pressure of \\<140mmHg and \\>100mmHg AND\n* Diastolic blood pressure \\<90mgHG and \\>60mmHg at screening.\n\nExclusion Criteria:\n\n* Cardiovascular, immune or infectious disease (e.g. HIV, HCV), or diabetes;\n* At screening, a 12-lead ECG demonstrating QTc\\>450 or QRS \\>120msec. If the QTc exceeds 450msec, or QRS exceeds 120msec, the ECG will be repeated x2 and the median of the three values will be used to determine the participant's eligibility.\n* Rheumatologic or autoimmune disease;\n* Vaccine administered within 4 weeks of study participation;\n* Viral or bacterial illness requiring medical attention and/or antibiotics within 3 months of study participation, or any illness or fever within 1 month of study participation;\n* Surgical procedure within 3 months of study participation;\n* Regular use of anti-inflammatory of immunomodulatory drugs (occasional use of NSAIDs is not an exclusion as long as the participant does not administer within 5 days of study participation);\n* Current use of opioid medication;\n* Current smoker or ceased smoking ≤12 months prior to participation;\n* High alcohol consumption;\n* Consumption of drugs of abuse (except alcohol);\n* Significant psychological comorbidity that in the discretion of the investigator compromises study integrity;\n* Current participation in any other research;\n* Ongoing litigation or worker's compensation claim;\n* Hospital Anxiety and Depression score indicating clinically significant depression;\n* Currently pregnant or positive screening urine pregnancy test;\n* Complete blood count values outside the normal clinical ranges, erythrocyte sedimentation rate (ESR) \\>60, C-reactive protein (CRP) \\>3, positive rheumatoid factor (RHF), or positive antinuclear antibodies (ANA).","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"55 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Ratio of Choline/ Creatine (CHO/CR) in the Brain From Baseline to 3 Hrs Post-endotoxin Administration","description":"The concentration of brain metabolite CHO will be measured via MRI scan as a measure of neuroinflammation. This measurement will be performed in both the control and experimental group. Increased CHO is a marker of increased cell turnover that can be seen during neuroinflammation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-.0021","spread":".01664"},{"groupId":"OG001","value":"-.0058","spread":".01465"}]}]}]},{"type":"PRIMARY","title":"Change in Ratio of Myoinositol/ Creatine (MI/CR) in the Brain From Baseline to 3hrs Post-endotoxin Administration","description":"The concentration of brain metabolite MI will be assessed via MRI scan as a measure of neuroinflammation. This measurement will be performed in both the control and experimental group. MI is a marker of microglia, and an acute increase in this metabolite could indicate microglia proliferation or accumulation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-.0049","spread":".31164"},{"groupId":"OG001","value":".1030","spread":".18022"}]}]}]},{"type":"PRIMARY","title":"Change in Brain Temperature From Baseline to 3 Hours Post-endotoxin Administration.","description":"The temperature of the brain will be assessed via MRI scan as a measure of neuroinflammation. This measurement will be performed in both the control and experimental group. Increased brain temperature certain areas may indicate an abnormally increased inflammatory response.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.10","spread":"0.44"},{"groupId":"OG001","value":"0.55","spread":"0.55"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":13},"commonTop":[]}}}